[Skip to Navigation]
Editorial
June 7, 2016

Who Should Be Screened for Lung Cancer? And Who Gets to Decide?

Author Affiliations
  • 1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena
JAMA. 2016;315(21):2279-2281. doi:10.1001/jama.2016.5986

Screening for lung cancer has come of age at a time when traditional approaches to mass screening are being challenged.1 For some cancers, physicians are moving slowly from a paternalistic model in which screening is considered mandatory for any patient who belongs to a defined high-risk group, to a newer patient-centered model in which the decision to screen is individualized and informed by a detailed discussion of potential benefits and harms. Conversations about cancer screening increasingly occur in the context of personalized medicine, individualized risk assessment, and shared decision making.

×